Clinical trial

Interventional Ablation for Early-stage Lung Cancer

NCT07005999

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2025-04-12

PhaseN/A

Study timeline

Study start (actual)2025-04-12Date precision: day

Registry last updated2025-06-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancer (NSCLC)unresolved

Early Stage Lung Non-Small Cell Carcinomaunresolved

Interventions

Sponsors & collaborators

Guangzhou Institute of Respiratory Diseaselead sponsor

Hunan Provincial People's Hospitalcollaborator

Beijing Chao Yang Hospitalcollaborator

Fuda Cancer Hospital, Guangzhoucollaborator

University of South China Affiliated Nanhua Hospitalcollaborator

Nanfang Hospital, Southern Medical Universitycollaborator

The First Affiliated Hospital of Guangzhou Medical Universitycollaborator

Sir Run Run Shaw Hospitalcollaborator

Eastern Theater General Hospital,QinHuai District Medical Areacollaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical Schoolcollaborator

Emergency General Hospitalcollaborator

The First Affiliated Hospital of Anhui Medical Universitycollaborator

The Second Hospital of Anhui Medical Universitycollaborator

Huaxi Hospitalcollaborator

Shanghai Chest Hospitalcollaborator

Chinese PLA General Hospitalcollaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07005999 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.